ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ ASX Shares
3 quality ASX 200 shares to buy and hold for a decade
Share Gainers
The CSL share price is up 35% in 12 months: Too late to invest?
Growth Shares
3 top buy and hold ASX healthcare shares to buy today
Growth Shares
Where to invest $25,000 in the ASX in 2019
Mergers & Acquisitions
ResMed Inc share price rises on Propeller Health acquisition
Share Market News
Leading brokers name 3 ASX shares to buy today
Share Market News
5 quality shares I'd like to buy in 2019
Growth Shares
Where to invest $5,000 in the ASX in January
Share Market News
5 things to watch on the ASX 200 on Thursday
Share Gainers
Why the ResMed share price just hit another record high
Share Market News
My top 10 ASX shares for 2018 in review
⏸️ ASX Shares
10 top ASX shares to buy in 2019
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
